RLI catalysts

    Catalysts and events linked to RLI, newest first.

    RLI stock catalysts and risks

    Latest published review: 2026-10-20

    DevelopmentTransmission channelEvidenceCondition to watch
    RLI beats Q3 estimates with 48% EPS surprise on specialty lines and yield
    2026-10-20 · Up
    higher fixed-income portfolio yields lifting net investment incomeRLI posted Q3 EPS of $0.86 vs $0.58 expected, with net investment income rising 13.1%.Not recorded
    RLI Beats Q3 Consensus with $0.86 EPS as Net Investment Income Jumps 13.1%
    2026-10-20 · Up
    net investment income growth boosting specialty insurance earningsQ3 EPS of $0.86 beat $0.58 estimate with net investment income growing 13.1%Not recorded
    RLI beats Q3 EPS by 48% on 13.1% jump in net investment income
    2026-10-20 · Up
    higher portfolio reinvestment yield boosting net investment incomeQ3 EPS beat by 48.28% driven by 13.1% growth in net investment income and $424.91M in net premiums earned.Not recorded
    RLI Corp Q3 EPS surges 48.3% over estimates as investment income grows
    2026-10-20 · Up
    net investment income yield accretion on float assetsRLI Q3 EPS of $0.86 beat consensus of $0.58 by 48.28%, with net investment income up 13.1%.Not recorded

    Do these developments change your position?

    Review RLI alongside your other holdings and identify which decision deserves attention first.

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    DateCardAvg 5d

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month